These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 7197975)
21. Pharmacokinetics of fleroxacin in renal impairment. Weidekamm E Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application. Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405 [TBL] [Abstract][Full Text] [Related]
23. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man. Schiantarelli P; Acerbi D; Bovis G Arzneimittelforschung; 1981; 31(1):92-7. PubMed ID: 6971114 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery. Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078 [TBL] [Abstract][Full Text] [Related]
25. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of etofylline after intravenous and oral administration to humans. Zuidema J; Verhoeven J; Merkus FW Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108 [TBL] [Abstract][Full Text] [Related]
27. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs. Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947 [TBL] [Abstract][Full Text] [Related]
28. Amezinium. Synthesis and radioactive labelling. Reicheneder F; Burger TF; König H; Kropp R; Lietz H; Thyes M; Wiersdorff WW Arzneimittelforschung; 1981; 31(9a):1529-33. PubMed ID: 7197967 [TBL] [Abstract][Full Text] [Related]
29. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs. Park BK; Lim JH; Kim MS; Hwang YH; Yun HI Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332 [TBL] [Abstract][Full Text] [Related]
32. Analytical determination and pharmacokinetics of robenacoxib in the dog. Jung M; Lees P; Seewald W; King JN J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tylosin in broiler chickens. Kowalski C; Roliński Z; Zań R; Wawron W Pol J Vet Sci; 2002; 5(3):127-30. PubMed ID: 12448074 [TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of toloxatone in man following intravenous and oral administrations. Benedetti MS; Rovei V; Dencker SJ; Nagy A; Johansson R Arzneimittelforschung; 1982; 32(3):276-80. PubMed ID: 7200786 [TBL] [Abstract][Full Text] [Related]
36. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice. Dunnick J Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke. Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats. Bhattaram VA; Paliwal JK; Gupta RC Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of mepindolol sulphate. Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882 [TBL] [Abstract][Full Text] [Related]